Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- Check4 days agoChange DetectedTwo new dates, 2026-04-01 and 2026-04-02, were added to the Study Record Dates, reflecting recent page edits.SummaryDifference0.1%

- Check11 days agoChange DetectedAdditions were made on 2026-03-24 and 2026-03-25. Deletions occurred on 2026-03-17 and 2026-03-18, affecting non-core sections of the page such as metadata and publications.SummaryDifference0.1%

- Check18 days agoChange DetectedSite release notes show an upgrade to version 3.5.0 with entries dated 2026-03-17 and 2026-03-18, replacing the previous version 3.4.3 dated 2026-03-10 and 2026-03-11.SummaryDifference0.1%

- Check26 days agoChange DetectedPage revision updated to v3.4.3 with new timestamps (2026-03-10 and 2026-03-11). Earlier revision details v3.4.2 (2025-11-22, 2025-12-08) were removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision tag 'Revision: v3.4.2' was added, and the older 'Revision: v3.4.1' notice along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedA government funding status notice has been added and the revision is updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.